Form 4: Tango Therapeutics CFO Daniella Beckman Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Daniella Beckman, CFO of Tango Therapeutics, sold shares of common stock on February 4th and 5th, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- Daniella Beckman, the Chief Financial Officer of Tango Therapeutics, sold shares of the company's common stock on February 4th and 5th, 2025.
- The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- On February 4th, 4,284 shares were sold at a weighted average price of $2.988 per share.
- On February 5th, 3,948 shares were sold at a weighted average price of $3.1614 per share.
- Following these transactions, Beckman directly owns 150,284 shares of Tango Therapeutics common stock.
Sentiment
Score: 5
Explanation: The Form 4 filing itself is neutral. It simply reports the sale of shares to cover tax obligations, a routine event. There's no inherent positive or negative sentiment associated with this type of transaction.
Industry Context
Sales of shares to cover tax obligations are a common practice among company executives, particularly after the vesting of restricted stock units. This activity doesn't necessarily reflect a negative outlook on the company's future prospects.
Comparison to Industry Standards
- Sell-to-cover policies are standard practice across publicly traded companies to manage tax obligations for employees receiving equity compensation.
- Comparable companies like Relay Therapeutics or Black Diamond Therapeutics also likely have similar policies in place for their executives.
Stakeholder Impact
- The sale of shares by the CFO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.
- The 'sell-to-cover' policy ensures that the CFO can meet her tax obligations without having to personally fund them, which is a benefit to the executive.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Daniella Beckman sold 4,284 shares of Tango Therapeutics common stock. |
| 02/05/2025 | Daniella Beckman sold 3,948 shares of Tango Therapeutics common stock. |
| 02/06/2025 | Date of signature for the Form 4 filing. |
Keywords
Tango Therapeutics, TNGX, Daniella Beckman, CFO, Form 4, Share Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.